Pay in 4 interest-free payments of $17.50 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
Eg5 InhibitorIII
TA 02 and SB203580 reduce the nuclear TCF/LEF-1 driven transcription of luciferase similar to DKK-1
and the IC50 value of the compound against CaM-KII is 10 μg/mL
is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities
26097-80-3
FLI-06 - Notch Pathway Modulator. CAS# 313967-18-9 Catalog No.:M60149-10S Eg5 InhibitorIIIFLI 06, CAS No. 313967 18 9, is a novel potent and selective small molecule intercepting Notch signaling and the early secretory pathway (EC50 ~2. 3 M), identified by using automated microscopy to monitor the trafficking and processing of a ligand independent Notch GFP fusion reporter. FLI 06 can induce accumulation of the reporter at the plasma membrane by interfering with transport in the secretory pathway. It can also disrupt the Golgi apparatus in
US$ 24.00
US$ 49.99
US$ 54.00
US$ 34.99
US$ 37.99
US$ 29.99
US$ 25.00
US$ 59.95
US$ 46.99
US$ 359.50